The Latest Cardiac and Vascular News
– TN-201 MYBPC3 gene therapy product candidate for the leading genetic cause of hypertrophic cardiomyopathy granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) – Expanded leadership team appointing Leone Patterson as Chief Financial and Business Officer and Matt Pollman, MD, as SVP, Clinical Development – Completed Initial Public […]
BAAR, Switzerland and MOUNTAIN VIEW, Calif., Sept. 8, 2021 /PRNewswire/ — atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects (ASD), today announced the appointment of Andrew Cleeland to the company’s Board of Directors. With over thirty years of experience, including specific expertise bringing game-changing technologies to […]
PIII Study for 496 ischemic stroke patients treated with endovascular thrombectomy First multi-target neuroprotectant for the intervention of ischemic brain injury Safety and efficacy verified in two phase II studies for ischemic stroke patients with recanalization therapy YONGIN, South Korea, Sept. 08, 2021 (GLOBE NEWSWIRE) — GNT Pharma Inc. today […]
Apabetalone, a First-in-Class Epigenetic Therapeutic Candidate, Met Key Endpoint of Lowering Pulmonary Vascular Resistance (PVR) and Was Well Tolerated Successful Completion and Promising Results of Investigator-led APPROACH-p Trial Sets the Stage for a Larger Multicenter Trial CALGARY, Alberta, Sept. 08, 2021 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) […]
Investor Insights highlights some of the top investors in Life Science and MedTech. This week host Ken Dropiewski interviews Maria Berkman, MD, Director, Head of MedTech for Broadview Ventures.
ANDOVER, Mass., Sept. 7, 2021 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of its OCS Heart System for […]
The combination of companies expands access to sudden cardiac arrest (SCA) preparedness solutions to customers nationwide BRENTWOOD, Tenn., Sept. 7, 2021 /PRNewswire/ — Cardio Partners, Inc., a company of Sarnova, Inc. and a national leader in providing emergency preparedness solutions, announced today that it has acquired Allied 100, LLC, a nationwide distributor of automated external […]
To Advise the Company’s Mitral Transcatheter Edge-to-edge Repair Project and the Company in General SUZHOU, China, Sept. 6, 2021 /PRNewswire/ — Peijia Medical Limited (HKEX: 9996) is pleased to announce Saibal Kar MD, FACC, FSCAI, board-certified interventional cardiologist has agreed to become our exclusive consultant in China to advise the research and development of our Mitral Transcatheter […]
Christopher Horton brings nearly 30 years of experience in the medical device and technology industry HINGHAM, Mass., Sept. 7, 2021 /PRNewswire/ — XACT Robotics®, the developer of the world’s first and only hands-free robotic system for CT-guided percutaneous procedures, the XACT ACE™ Robotic System, today announced that Christopher Horton has joined the company as […]
A peer-reviewed publication in the September 2021 edition of PharmacoEconomics shows an estimated 12.3£ million savings to the English health care system per 100,000 eligible patients when using the Acarix CADScor system to rule out coronary artery disease (CAD). Coronary artery disease (CAD) is the most common heart and circulatory […]
